APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyclin Dependent Kinase 1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cyclin Dependent Kinase 1 Industry Growth and Trends Forecast to 2032

22 December 202590 pages

Choose your research edition.

Industry ResearchCyclin Dependent Kinase 1 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclin Dependent Kinase 1 Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Cyclin Dependent Kinase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclin Dependent Kinase 1 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclin Dependent Kinase 1 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cyclin Dependent Kinase 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cyclin Dependent Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cyclin Dependent Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclin Dependent Kinase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyclin Dependent Kinase 1 include Tragara Pharmaceuticals Inc, Tiziana Life Sciences Plc, Presage Biosciences Inc, ChoDang Pharm Co Ltd and Astex Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cyclin Dependent Kinase 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cyclin Dependent Kinase 1 market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cyclin Dependent Kinase 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cyclin Dependent Kinase 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cyclin Dependent Kinase 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cyclin Dependent Kinase 1 Market by Company

Tragara Pharmaceuticals Inc

Tiziana Life Sciences Plc

Presage Biosciences Inc

ChoDang Pharm Co Ltd

Astex Pharmaceuticals Inc

Cyclin Dependent Kinase 1 Segment by Type

Milciclib

CD-650

AT-7519

Others

Cyclin Dependent Kinase 1 Segment by Application

Relapsed Chronic Lymphocytic Leukemia

Lymphoma

Gliosarcoma

Others

Cyclin Dependent Kinase 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclin Dependent Kinase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclin Dependent Kinase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclin Dependent Kinase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyclin Dependent Kinase 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cyclin Dependent Kinase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Milciclib Table 2. Major Company of CD-650 Table 3. Major Company of AT-7519 Table 4. Major Company of Others Table 5. Global Cyclin Dependent Kinase 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (k units) Table 7. Global Cyclin Dependent Kinase 1 Sales Market Share in Volume by Type (2021-2026) Table 8. Global Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 9. Global Cyclin Dependent Kinase 1 Sales Market Share in Value by Type (2021-2026) Table 10. Global Cyclin Dependent Kinase 1 Price by Type (2021-2026) & (US$/unit) Table 11. Global Cyclin Dependent Kinase 1 Sales by Type (2027-2032) & (k units) Table 12. Global Cyclin Dependent Kinase 1 Sales Market Share in Volume by Type (2027-2032) Table 13. Global Cyclin Dependent Kinase 1 Sales by Type (2027-2032) & (US$ Million) Table 14. Global Cyclin Dependent Kinase 1 Sales Market Share in Value by Type (2027-2032) Table 15. Global Cyclin Dependent Kinase 1 Price by Type (2027-2032) & (US$/unit) Table 16. North America Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (k units) Table 17. North America Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (k units) Table 19. Europe Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (k units) Table 23. Latin America Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Cyclin Dependent Kinase 1 Sales by Type (2021-2026) & (US$ Million) Table 26. Cyclin Dependent Kinase 1 Industry Trends Table 27. Cyclin Dependent Kinase 1 Industry Drivers Table 28. Cyclin Dependent Kinase 1 Industry Opportunities and Challenges Table 29. Cyclin Dependent Kinase 1 Industry Restraints Table 30. Global Cyclin Dependent Kinase 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Cyclin Dependent Kinase 1 Revenue Market Share by Company (2021-2026) Table 32. Global Cyclin Dependent Kinase 1 Sales by Company (2021-2026) & (k units) Table 33. Global Cyclin Dependent Kinase 1 Sales Share by Company (2021-2026) Table 34. Global Cyclin Dependent Kinase 1 Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Cyclin Dependent Kinase 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Cyclin Dependent Kinase 1 Major Company Production Sites and Headquarters Table 37. Global Cyclin Dependent Kinase 1 Company, Product Type & Application Table 38. Global Cyclin Dependent Kinase 1 Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Cyclin Dependent Kinase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Cyclin Dependent Kinase 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Cyclin Dependent Kinase 1 Sales by Region (2021-2026) & (k units) Table 43. Global Cyclin Dependent Kinase 1 Sales Market Share in Volume by Region (2021-2026) Table 44. Global Cyclin Dependent Kinase 1 Sales by Region (2021-2026) & (US$ Million) Table 45. Global Cyclin Dependent Kinase 1 Sales Market Share in Value by Region (2021-2026) Table 46. Global Cyclin Dependent Kinase 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Cyclin Dependent Kinase 1 Sales by Region (2027-2032) & (k units) Table 48. Global Cyclin Dependent Kinase 1 Sales Market Share in Volume by Region (2027-2032) Table 49. Global Cyclin Dependent Kinase 1 Sales by Region (2027-2032) & (US$ Million) Table 50. Global Cyclin Dependent Kinase 1 Sales Market Share in Value by Region (2027-2032) Table 51. Global Cyclin Dependent Kinase 1 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Cyclin Dependent Kinase 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (k units) Table 54. Global Cyclin Dependent Kinase 1 Sales Market Share in Volume by Application (2021-2026) Table 55. Global Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 56. Global Cyclin Dependent Kinase 1 Sales Market Share in Value by Application (2021-2026) Table 57. Global Cyclin Dependent Kinase 1 Price by Application (2021-2026) & (US$/unit) Table 58. Global Cyclin Dependent Kinase 1 Sales by Application (2027-2032) & (k units) Table 59. Global Cyclin Dependent Kinase 1 Sales Market Share in Volume by Application (2027-2032) Table 60. Global Cyclin Dependent Kinase 1 Sales by Application (2027-2032) & (US$ Million) Table 61. Global Cyclin Dependent Kinase 1 Sales Market Share in Value by Application (2027-2032) Table 62. Global Cyclin Dependent Kinase 1 Price by Application (2027-2032) & (US$/unit) Table 63. North America Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (k units) Table 64. North America Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (k units) Table 66. Europe Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (k units) Table 70. Latin America Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Cyclin Dependent Kinase 1 Sales by Application (2021-2026) & (US$ Million) Table 73. Tragara Pharmaceuticals Inc Company Information Table 74. Tragara Pharmaceuticals Inc Business Overview Table 75. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio Table 77. Tragara Pharmaceuticals Inc Recent Development Table 78. Tiziana Life Sciences Plc Company Information Table 79. Tiziana Life Sciences Plc Business Overview Table 80. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product Portfolio Table 82. Tiziana Life Sciences Plc Recent Development Table 83. Presage Biosciences Inc Company Information Table 84. Presage Biosciences Inc Business Overview Table 85. Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Presage Biosciences Inc Cyclin Dependent Kinase 1 Product Portfolio Table 87. Presage Biosciences Inc Recent Development Table 88. ChoDang Pharm Co Ltd Company Information Table 89. ChoDang Pharm Co Ltd Business Overview Table 90. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product Portfolio Table 92. ChoDang Pharm Co Ltd Recent Development Table 93. Astex Pharmaceuticals Inc Company Information Table 94. Astex Pharmaceuticals Inc Business Overview Table 95. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio Table 97. Astex Pharmaceuticals Inc Recent Development Table 98. North America Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 99. North America Cyclin Dependent Kinase 1 Sales by Country (2021-2026) & (k units) Table 100. North America Cyclin Dependent Kinase 1 Sales Market Share by Country (2021-2026) Table 101. North America Cyclin Dependent Kinase 1 Sales Forecast by Country (2027-2032) & (k units) Table 102. North America Cyclin Dependent Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 103. North America Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Cyclin Dependent Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Cyclin Dependent Kinase 1 Market Share by Country (2021-2026) Table 106. North America Cyclin Dependent Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Cyclin Dependent Kinase 1 Market Share Forecast by Country (2027-2032) Table 108. Europe Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 109. Europe Cyclin Dependent Kinase 1 Sales by Country (2021-2026) & (k units) Table 110. Europe Cyclin Dependent Kinase 1 Sales Market Share by Country (2021-2026) Table 111. Europe Cyclin Dependent Kinase 1 Sales Forecast by Country (2027-2032) & (k units) Table 112. Europe Cyclin Dependent Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Cyclin Dependent Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Cyclin Dependent Kinase 1 Market Share by Country (2021-2026) Table 116. Europe Cyclin Dependent Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Cyclin Dependent Kinase 1 Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Cyclin Dependent Kinase 1 Sales by Country (2021-2026) & (k units) Table 120. Asia-Pacific Cyclin Dependent Kinase 1 Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Cyclin Dependent Kinase 1 Sales Forecast by Country (2027-2032) & (k units) Table 122. Asia-Pacific Cyclin Dependent Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Cyclin Dependent Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Cyclin Dependent Kinase 1 Market Share by Country (2021-2026) Table 126. Asia-Pacific Cyclin Dependent Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Cyclin Dependent Kinase 1 Market Share Forecast by Country (2027-2032) Table 128. Latin America Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Latin America Cyclin Dependent Kinase 1 Sales by Country (2021-2026) & (k units) Table 130. Latin America Cyclin Dependent Kinase 1 Sales Market Share by Country (2021-2026) Table 131. Latin America Cyclin Dependent Kinase 1 Sales Forecast by Country (2027-2032) & (k units) Table 132. Latin America Cyclin Dependent Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Cyclin Dependent Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Cyclin Dependent Kinase 1 Market Share by Country (2021-2026) Table 136. Latin America Cyclin Dependent Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Cyclin Dependent Kinase 1 Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country (2021-2026) & (k units) Table 140. Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Cyclin Dependent Kinase 1 Sales Forecast by Country (2027-2032) & (k units) Table 142. Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Cyclin Dependent Kinase 1 Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Cyclin Dependent Kinase 1 Market Share by Country (2021-2026) Table 146. Middle East and Africa Cyclin Dependent Kinase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Cyclin Dependent Kinase 1 Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Cyclin Dependent Kinase 1 Distributors List Table 151. Cyclin Dependent Kinase 1 Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Cyclin Dependent Kinase 1 Image Figure 2. Global Cyclin Dependent Kinase 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclin Dependent Kinase 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyclin Dependent Kinase 1 Sales (2021-2032) & (k units) Figure 5. Milciclib Image Figure 6. Global Milciclib Sales YoY Growth (2021-2032) & (k units) Figure 7. CD-650 Image Figure 8. Global CD-650 Sales YoY Growth (2021-2032) & (k units) Figure 9. AT-7519 Image Figure 10. Global AT-7519 Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Cyclin Dependent Kinase 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Cyclin Dependent Kinase 1 Market Share by Type 2025 VS 2032 Figure 15. North America Cyclin Dependent Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 16. North America Cyclin Dependent Kinase 1 Sales Market Share in Value by Type in 2025 Figure 17. Europe Cyclin Dependent Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 18. Europe Cyclin Dependent Kinase 1 Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Cyclin Dependent Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Cyclin Dependent Kinase 1 Sales Market Share in Value by Type in 2025 Figure 21. Latin America Cyclin Dependent Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Cyclin Dependent Kinase 1 Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Cyclin Dependent Kinase 1 Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Relapsed Chronic Lymphocytic Leukemia Image Figure 28. Global Relapsed Chronic Lymphocytic Leukemia Sales YoY Growth (2021-2032) & (k units) Figure 29. Lymphoma Image Figure 30. Global Lymphoma Sales YoY Growth (2021-2032) & (k units) Figure 31. Gliosarcoma Image Figure 32. Global Gliosarcoma Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Cyclin Dependent Kinase 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Cyclin Dependent Kinase 1 Market Share by Application 2025 VS 2032 Figure 37. North America Cyclin Dependent Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 38. North America Cyclin Dependent Kinase 1 Sales Market Share in Value by Application in 2025 Figure 39. Europe Cyclin Dependent Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 40. Europe Cyclin Dependent Kinase 1 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Cyclin Dependent Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Cyclin Dependent Kinase 1 Sales Market Share in Value by Application in 2025 Figure 43. Latin America Cyclin Dependent Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Cyclin Dependent Kinase 1 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Cyclin Dependent Kinase 1 Sales Market Share in Value by Application in 2025 Figure 47. North America Cyclin Dependent Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Cyclin Dependent Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Cyclin Dependent Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Cyclin Dependent Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Cyclin Dependent Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Cyclin Dependent Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Cyclin Dependent Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Cyclin Dependent Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Cyclin Dependent Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Cyclin Dependent Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Cyclin Dependent Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Cyclin Dependent Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Cyclin Dependent Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Cyclin Dependent Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Cyclin Dependent Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Cyclin Dependent Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Cyclin Dependent Kinase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Cyclin Dependent Kinase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Cyclin Dependent Kinase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Cyclin Dependent Kinase 1 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Cyclin Dependent Kinase 1 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Milciclib
  • CD-650
  • AT-7519
  • Others
Applications
  • Relapsed Chronic Lymphocytic Leukemia
  • Lymphoma
  • Gliosarcoma
  • Others
Companies covered
  • Tragara Pharmaceuticals Inc
  • Tiziana Life Sciences Plc
  • Presage Biosciences Inc
  • ChoDang Pharm Co Ltd
  • Astex Pharmaceuticals Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyclin Dependent Kinase 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cyclin Dependent Kinase 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cyclin Dependent Kinase 1 Market by Type
  6. 1.3.1 Milciclib
  7. 1.3.2 CD-650
  8. 1.3.3 AT-7519
  9. 1.3.4 Others
  10. 1.4 Global Cyclin Dependent Kinase 1 Market Size by Type
  11. 1.4.1 Global Cyclin Dependent Kinase 1 Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Cyclin Dependent Kinase 1 Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Cyclin Dependent Kinase 1 Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Cyclin Dependent Kinase 1 Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Cyclin Dependent Kinase 1 Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Cyclin Dependent Kinase 1 Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Cyclin Dependent Kinase 1 Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Cyclin Dependent Kinase 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cyclin Dependent Kinase 1 Industry Trends
  2. 2.2 Cyclin Dependent Kinase 1 Industry Drivers
  3. 2.3 Cyclin Dependent Kinase 1 Industry Opportunities and Challenges
  4. 2.4 Cyclin Dependent Kinase 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cyclin Dependent Kinase 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Cyclin Dependent Kinase 1 Sales (2021-2026)
  3. 3.3 Global Top Players by Cyclin Dependent Kinase 1 Price (2021-2026)
  4. 3.4 Global Cyclin Dependent Kinase 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyclin Dependent Kinase 1 Major Company Production Sites & Headquarters
  6. 3.6 Global Cyclin Dependent Kinase 1 Company, Product Type & Application
  7. 3.7 Global Cyclin Dependent Kinase 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyclin Dependent Kinase 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyclin Dependent Kinase 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyclin Dependent Kinase 1 Tier 1, Tier 2, and Tier 3
4 Cyclin Dependent Kinase 1 Regional Status and Outlook
  1. 4.1 Global Cyclin Dependent Kinase 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cyclin Dependent Kinase 1 Historic Market Size by Region
  3. 4.2.1 Global Cyclin Dependent Kinase 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cyclin Dependent Kinase 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cyclin Dependent Kinase 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cyclin Dependent Kinase 1 Forecasted Market Size by Region
  7. 4.3.1 Global Cyclin Dependent Kinase 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cyclin Dependent Kinase 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cyclin Dependent Kinase 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cyclin Dependent Kinase 1 by Application
  1. 5.1 Cyclin Dependent Kinase 1 Market by Application
  2. 5.1.1 Relapsed Chronic Lymphocytic Leukemia
  3. 5.1.2 Lymphoma
  4. 5.1.3 Gliosarcoma
  5. 5.1.4 Others
  6. 5.2 Global Cyclin Dependent Kinase 1 Market Size by Application
  7. 5.2.1 Global Cyclin Dependent Kinase 1 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cyclin Dependent Kinase 1 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cyclin Dependent Kinase 1 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cyclin Dependent Kinase 1 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cyclin Dependent Kinase 1 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cyclin Dependent Kinase 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cyclin Dependent Kinase 1 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cyclin Dependent Kinase 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Tragara Pharmaceuticals Inc
  2. 6.1.1 Tragara Pharmaceuticals Inc Company Information
  3. 6.1.2 Tragara Pharmaceuticals Inc Business Overview
  4. 6.1.3 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio
  6. 6.1.5 Tragara Pharmaceuticals Inc Recent Developments
  7. 6.2 Tiziana Life Sciences Plc
  8. 6.2.1 Tiziana Life Sciences Plc Company Information
  9. 6.2.2 Tiziana Life Sciences Plc Business Overview
  10. 6.2.3 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product Portfolio
  12. 6.2.5 Tiziana Life Sciences Plc Recent Developments
  13. 6.3 Presage Biosciences Inc
  14. 6.3.1 Presage Biosciences Inc Company Information
  15. 6.3.2 Presage Biosciences Inc Business Overview
  16. 6.3.3 Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Presage Biosciences Inc Cyclin Dependent Kinase 1 Product Portfolio
  18. 6.3.5 Presage Biosciences Inc Recent Developments
  19. 6.4 ChoDang Pharm Co Ltd
  20. 6.4.1 ChoDang Pharm Co Ltd Company Information
  21. 6.4.2 ChoDang Pharm Co Ltd Business Overview
  22. 6.4.3 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product Portfolio
  24. 6.4.5 ChoDang Pharm Co Ltd Recent Developments
  25. 6.5 Astex Pharmaceuticals Inc
  26. 6.5.1 Astex Pharmaceuticals Inc Company Information
  27. 6.5.2 Astex Pharmaceuticals Inc Business Overview
  28. 6.5.3 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio
  30. 6.5.5 Astex Pharmaceuticals Inc Recent Developments
7 North America by Country
  1. 7.1 North America Cyclin Dependent Kinase 1 Sales by Country
  2. 7.1.1 North America Cyclin Dependent Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cyclin Dependent Kinase 1 Sales by Country (2021-2026)
  4. 7.1.3 North America Cyclin Dependent Kinase 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cyclin Dependent Kinase 1 Market Size by Country
  6. 7.2.1 North America Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cyclin Dependent Kinase 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Cyclin Dependent Kinase 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cyclin Dependent Kinase 1 Sales by Country
  2. 8.1.1 Europe Cyclin Dependent Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cyclin Dependent Kinase 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Cyclin Dependent Kinase 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cyclin Dependent Kinase 1 Market Size by Country
  6. 8.2.1 Europe Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cyclin Dependent Kinase 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cyclin Dependent Kinase 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cyclin Dependent Kinase 1 Sales by Country
  2. 9.1.1 Asia-Pacific Cyclin Dependent Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cyclin Dependent Kinase 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cyclin Dependent Kinase 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cyclin Dependent Kinase 1 Market Size by Country
  6. 9.2.1 Asia-Pacific Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cyclin Dependent Kinase 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cyclin Dependent Kinase 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cyclin Dependent Kinase 1 Sales by Country
  2. 10.1.1 South America Cyclin Dependent Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cyclin Dependent Kinase 1 Sales by Country (2021-2026)
  4. 10.1.3 South America Cyclin Dependent Kinase 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cyclin Dependent Kinase 1 Market Size by Country
  6. 10.2.1 South America Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cyclin Dependent Kinase 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Cyclin Dependent Kinase 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country
  2. 11.1.1 Middle East and Africa Cyclin Dependent Kinase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cyclin Dependent Kinase 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cyclin Dependent Kinase 1 Market Size by Country
  6. 11.2.1 Middle East and Africa Cyclin Dependent Kinase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cyclin Dependent Kinase 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cyclin Dependent Kinase 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cyclin Dependent Kinase 1 Value Chain Analysis
  2. 12.1.1 Cyclin Dependent Kinase 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cyclin Dependent Kinase 1 Production Mode & Process
  7. 12.2 Cyclin Dependent Kinase 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cyclin Dependent Kinase 1 Distributors
  10. 12.2.3 Cyclin Dependent Kinase 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst